CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

S. S. Kenderian, M. Ruella, O. Shestova, M. Klichinsky, V. Aikawa, J. J.D. Morrissette, J. Scholler, D. Song, D. L. Porter, M. Carroll, C. H. June, S. Gill

Research output: Contribution to journalArticlepeer-review

206 Scopus citations

Fingerprint Dive into the research topics of 'CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences